The Impact of Humalog and Humulin R on the Blood Glucose Fluctuation in Diabetic Patients after Meal_West China Medical Journal

Authors：

Department of Endocrinology, People’s Hospital of Jianyang City, Jianyang Sichuan 641400,China;

Corresponding author：

Keywords：

优泌乐; 糖尿病; 血糖波动

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

目的:比较优泌乐(赖脯胰岛素)与优泌林R(常规人胰岛素)改善餐后2 h血糖波动疗效。方法:报道本院369例糖尿病患者强化治疗。结果:优泌乐治疗组餐后2 h血糖水平及血糖波动均显著降低,且无任何显著性不良事件或持久性低血糖发生.结论:优泌乐能够快速有效控制2型糖尿病患者的餐后血糖,方便患者,顺应性好,获得患者的喜爱。

Citation： ZENG Zhi. The Impact of Humalog and Humulin R on the Blood Glucose Fluctuation in Diabetic Patients after Meal. West China Medical Journal, 2009, 24(9): 2317-2318. doi: Copy

1.	ANDERSON JH JR, BRUNELLE RL,KEOHANE P, et al. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with noninsulindependent diabetes mellitus[J]. Arch Int Med, 1997,157(11):1249-1255.
2.	HEISE T, WEYER C, SERWAS A, et al. Timeaction profiles of novel premixed preparations of insulin lispro and NPL insulin[J]. Diabetes Care, 1998,21(5):800-803.
3.	ANDERSON JH JR, BRUNELLE RL, KOIVISTO VA,et al. Improved mealtime treatment of diabetes mellitus using an insulin analogue.[J]. Clin Ther, 1997,19(1):62-72.
4.	HOWEY DC, BOWSHER RR, BRUNELLE RL, et al.[Lys(B28), Pro(B29)]human insulin. A rapidly absorbed analogue of human insulin[J]. Diabetes, 1994, 43(3):396-402.
5.	LALLI C, CIOFETTA M, DEL SINDACO P, et al. Longterm intensive treatment of type 1 diabetes with the shortacting insulin analog lispro in variable combination with NPH insulin at mealtime[J]. Diabetes Care, 1999,22(3):468-477.
6.	ROACH P, YUE ARORA V, et al. Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protaminebased insulin lispro formulation[J]. Diabetes Care, 1999,22(8):1258-1261.

1. ANDERSON JH JR, BRUNELLE RL,KEOHANE P, et al. Mealtime treatment with insulin analog improves postprandial hyperglycemia and hypoglycemia in patients with noninsulindependent diabetes mellitus[J]. Arch Int Med, 1997,157(11):1249-1255.
2. HEISE T, WEYER C, SERWAS A, et al. Timeaction profiles of novel premixed preparations of insulin lispro and NPL insulin[J]. Diabetes Care, 1998,21(5):800-803.
3. ANDERSON JH JR, BRUNELLE RL, KOIVISTO VA,et al. Improved mealtime treatment of diabetes mellitus using an insulin analogue.[J]. Clin Ther, 1997,19(1):62-72.
4. HOWEY DC, BOWSHER RR, BRUNELLE RL, et al.[Lys(B28), Pro(B29)]human insulin. A rapidly absorbed analogue of human insulin[J]. Diabetes, 1994, 43(3):396-402.
5. LALLI C, CIOFETTA M, DEL SINDACO P, et al. Longterm intensive treatment of type 1 diabetes with the shortacting insulin analog lispro in variable combination with NPH insulin at mealtime[J]. Diabetes Care, 1999,22(3):468-477.
6. ROACH P, YUE ARORA V, et al. Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protaminebased insulin lispro formulation[J]. Diabetes Care, 1999,22(8):1258-1261.

West China Medical Journal

The Impact of Humalog and Humulin R on the Blood Glucose Fluctuation in Diabetic Patients after Meal

Abstract Full text Figures/Tables Video References Cited by

Format

Content